Abstract GS01-03: Adding Atezolizumab to Adjuvant Chemotherapy for Stage II and III Triple-Negative Breast Cancer is Unlikely to Improve Efficacy: Interim Analysis of the ALEXANDRA/IMpassion030 Phase 3 Trial Michail Ignatiadis , Andrew Bailey , Heather McArthur , Sarra El-Abed , Evandro de Azambuja , Otto Metzger , Steve Chui , Max Dieterich , Thomas Perretti , Guenther Steger , Jacek Jassem , Soo Chin Lee , Michaela Higgins , José Zarbá , Marcus Schmidt , Henry Gomez , Angel Guerrero-Zotano , Luca Moscetti , Joanne Win Yang Chiu , Carter DuFrane , Vanessa Honvault , Rosa Altarcheh , Luciana Molinero , Andrew Ellingson , Elisabetta Munzone , Noa Efrat Ben-Baruch , Emilio Bajetta , Shinji Ohno , Seock-Ah Im , Gustavo Werutsky , Einav Gal-Yam , Xavier Gonzalez-Farré , Ling-Ming Tseng , William Jacot , Oleg Gluz , Zhimin Shao , Yaroslav Shparyk , Ivan Sinielnikov , Zimina Anastasia , Aleksandr Vasiliev , Esther Shearer-Kang , Eric Winer , Diogo Martins-Branco , Shona Fielding , David Cameron , Giuseppe Viale , Shigehira Saji , Richard Gelber , Martine Piccart Cancer Research（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
